The Aberdeen-based company also said in was in “active discussions to out-licence” the clinical development of its product.
Novexatin has been proven so far to rapidly clear fungal nail infection.
- Text size
NovaBiotics prepares to out-licence nail product
Novabiotics, the Scottish biotechnology company focused on the design and development of antifungal and antibacterial therapies, successfully completed the dosing initial analysis of its phase IIa clinical trials for Novexatin, a brush-on treatment for fungal nail infection.
Commenting & Moderation
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
MOST READ
SPONSORED LINKS
MOST COMMENTED
